403
Views
6
CrossRef citations to date
0
Altmetric
Review

The potential of class 3 semaphorins as both targets and therapeutics in cancer

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ramesh Butti, Totakura VS Kumar, Ramakrishna Nimma & Gopal C Kundu. (2018) Impact of semaphorin expression on prognostic characteristics in breast cancer. Breast Cancer: Targets and Therapy 10, pages 79-88.
Read now

Articles from other publishers (5)

Marco Arese, Federico Bussolino, Margherita Pergolizzi & Laura Bizzozero. (2022) An Overview of the Molecular Cues and Their Intracellular Signaling Shared by Cancer and the Nervous System: From Neurotransmitters to Synaptic Proteins, Anatomy of an All-Inclusive Cooperation. International Journal of Molecular Sciences 23:23, pages 14695.
Crossref
Ruoyan Liu, Yanjie Shuai, Jingtao Luo & Ze Zhang. (2019) SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis. Frontiers in Oncology 9.
Crossref
Samuel Garcia. (2019) Role of Semaphorins in Immunopathologies and Rheumatic Diseases. International Journal of Molecular Sciences 20:2, pages 374.
Crossref
Svetlana P. Chapoval. (2018) Neuroimmune semaphorins as costimulatory molecules and beyond. Molecular Medicine 24:1.
Crossref
Hesam Movassagh, Abeer Saati, Saravanan Nandagopal, Ashfaque Mohammed, Nazanin Tatari, Lianyu Shan, Jonathan S. Duke-Cohan, Keith R. Fowke, Francis Lin & Abdelilah S. Gounni. (2017) Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo. The Journal of Immunology 198:3, pages 1023-1033.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.